Besluiten t.b.v. 2024
|
|
|
|
|
|
|
|
|
|
Pakket |
Leverancier |
Jaar |
Opmerkingen |
|
Albumine |
Prothya B.v. |
1 |
|
|
Anagrelide |
Accord Healthcare B.v. |
2 |
|
|
Apremilast |
Amgen B.v. |
2 |
|
|
Bortezemib |
Accord Healthcare B.v. |
2 |
|
|
Calcium Met Vitamine D |
Eurocept International Bv |
2 |
Niet exclusief |
|
Carboplatine |
Fresenius Kabi Nederland Bv |
3 |
|
|
Cefazoline |
Mylan B.V. |
1 |
|
|
Ciprofloxacine |
Aurobindo Pharma Bv |
3 |
|
|
Cisplatine |
Accord Healthcare B.v. |
2 |
|
|
Clindamycine |
Added Pharma Bv |
1 |
|
|
Docetaxel |
Accord Healthcare B.v. |
2 |
|
|
Doxorubicine |
Aurobindo Pharma Bv |
3 |
|
|
Encorafenib |
Pierre Fabre Sante Benelux Sa |
1 |
|
|
Epoetine / Aranesp |
Amgen B.v. |
3 |
Niet exclusief |
|
Epoetine / Binocrit |
Sandoz Bv |
2 |
Niet exclusief |
|
Epoetine / Neorecoron |
Roche Nederland Bv |
1 |
Niet exclusief |
|
Filgrastim |
Accord Healthcare B.v. |
2 |
|
|
Fulvestrant |
Glenmark Pharmaceuticals B.v. |
2 |
|
|
Gadoteerzuur |
GE Healthcare B.V. |
2 |
|
|
Gemcitabine |
Sandoz Bv |
2 |
|
|
Granisetron Oraal |
Pharmanovia Benelux Bv |
1 |
|
|
Hepatitis B Engerix / Fendrix |
Glaxosmithkline B.v. |
3 |
Niet exclusief |
|
Hepatitis B PreHevbri |
Valneva France Sas |
3 |
Niet exclusief |
|
Immunoglobuline, Normaal, Intravasculair 20 kg |
Prothya B.v. |
2 |
|
|
Immunoglobuline, Normaal, Intravasculair 80 kg |
Csl Behring Bv |
2 |
|
|
Indigokarmijn |
Pharmanovia Benelux Bv |
1 |
|
|
Irinotecan |
Fresenius Kabi Nederland Bv |
3 |
|
|
Jodixanol |
GE Healthcare B.V. |
2 |
|
|
Johexol |
GE Healthcare B.V. |
2 |
|
|
Macrogol |
Norgine Pharma B.v. |
1 |
|
|
Magnesiumsulfaat |
Eureco Pharma |
3 |
|
|
Methoxypolyethyleenglycolepoetine Beta |
Roche Nederland Bv |
1 |
|
|
Naloxon |
Hameln Pharma Gmbh |
2 |
|
|
Oxaliplatine |
Fresenius Kabi Nederland Bv |
3 |
|
|
Oxytocine |
Eureco Pharma |
3 |
|
|
Picozwavelzuur |
Ferring Bv |
3 |
|
|
Protrombinecomplex |
Prothya B.v. |
1 |
|
|
Voriconazol |
Eureco Pharma |
3 |
|
|
Zoledroninezuur |
Accord Healthcare B.v. |
2 |
|
|
|
|
|
|
|
Vervallen |
|
|
|
|
Bariumsulfaat Met Suspendeermiddelen |
VERVALLEN |
0 |
VERVALLEN |
|
Jomeprol |
VERVALLEN |
0 |
VERVALLEN |
|
Paracetamol zetpillen |
VERVALLEN |
0 |
VERVALLEN |
|
|
|
|
|
|
Tijdelijk besloten |
|
|
|
|
Tocilizumab |
Roche |
? |
Niet exclusief. In afwachting van biosimilair. |
|
|
|
|
|
|
Al besloten in 2023 |
|
|
|
|
Abirateron |
Accord Healthcare B.v. |
2 |
|
|
Dasatinib |
Pharmachemie Bv |
2 |
|
|
Everolimus |
Sandoz Bv |
2 |
|
|
Sunitinib |
Accord Healthcare B.v. |
2 |
|
|
Bevacizumab |
Celltrion Healthcare Netherlands B.v. |
2 |
|
|
Infliximab |
Celltrion Healthcare Netherlands B.v. |
1 |
|
|
Rituximab |
Sandoz Bv |
3 |
|
|
Trastuzumab |
Roche Nederland Bv |
1 |
|
|
Sugammadex |
Centrafarm Bv |
1,5 |
|
|
|
|
|
|
|
Nog te beslissen |
|
Atropine |
|
|
|
|
Clemastine |
|
|
|
|
Etoposide |
|
|
|
|
Iloprost |
|
|
|
|
Lacosamide |
|
|
|